PF-04577806 is a potent, selective, and ATP-competitive inhibitor of protein kinase C (PKC); it exhibits inhibitory activity against PKCα, PKCβI, PKCβII, PKCγ, and PKCθ with IC50 values of 2.4 nM, 8.1 nM, 6.9 nM, 45.9 nM, and 29.5 nM, respectively; it can reverse retinal vascular leakage in diabetic rats.